sorafenib has been researched along with ki16425 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (ki16425) | Trials (ki16425) | Recent Studies (post-2010) (ki16425) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 18 | 0 | 12 |
| Protein | Taxonomy | sorafenib (IC50) | ki16425 (IC50) |
|---|---|---|---|
| Lysophosphatidic acid receptor 1 | Rattus norvegicus (Norway rat) | 0.16 | |
| Lysophosphatidic acid receptor 1 | Homo sapiens (human) | 0.4556 | |
| Lysophosphatidic acid receptor 2 | Homo sapiens (human) | 1.2 | |
| Lysophosphatidic acid receptor 3 | Homo sapiens (human) | 0.9505 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dalton, JT; Li, CM; Li, W; Lu, Y; Miller, DD; Wang, Z | 1 |
1 other study(ies) available for sorafenib and ki16425
| Article | Year |
|---|---|
Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.
Topics: Amides; Animals; Antineoplastic Agents; Carboxylic Acids; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship; Thiazolidines; Tumor Cells, Cultured | 2010 |